跳至主要内容
临床试验/CTRI/2024/05/067145
CTRI/2024/05/067145尚未招募不适用

CLINICAL UTILITY OF BOERICKE’S MATERIA MEDICA IN CASE OF HYDRONEPHROSIS.

Dr Dinesh Chand1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年5月20日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
To compare and analyse the difference in the Hydronephrosis Severity Score before and after 6 months of treatment to know the utility of individualized homoeopathic medicine.

研究概览

简要总结

This is a prospective, single arm, open label, interventional clinical study. Hydroureter and hydronephrosis are common entities encountered in primary care medicine, emergency medicine as well as nephrology and urology practices. Hydronephrosis is defined as dilatation and distension of the renal collecting system of one or both kidneys due to obstruction of urine outflow distal to the renal pelvis (i.e., ureter, urinary bladder, and urethra). Hydronephrosis remains the most challenging renal disorder with a high burden of disease. Symptomatic early-stage hydronephrosis urgently needs to be identified and defined, as efficient early-stage case finding and diagnosis in primary care would enable health-care providers to proactively and substantially reduce the burden of disease through proper management including structured education, prevention of other renal disease like renal cyst, addressing lifestyle-related risk factors for disease progression. The aim of this study is to assess the clinical utility of individualized homoeopathic medicine in the management of cases of hydronephrosis by using Boericke’s materia medica. A total number of 30 patients suffering from hydronephrosis & fulfilling the eligibility criteria will be selected from OPD of SNHMC.Data will be collected on the basis of detailed case-taking from patient , physician’s observation and calculation of Hydronephrosis severity score. Outcome will be assessed at baseline and every month up to 6months.Data obtained after the management of 6 months will be analyzed to draw the inference using appropriate statistical tools.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
25.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Patient of age between 25 years to 70 years and of both sexes.
  • Patient suffering from Hydronephrosis who are willing to give consent to participate in the study.

排除标准

  • Patient of age below 25 years.
  • Patient suffering from congenital anomaly.
  • Any other condition requiring emergency or surgical intervention.
  • Patient unwilling for inclusion in the study and those who are not able to come for follow-up.

结局指标

主要结局

To compare and analyse the difference in the Hydronephrosis Severity Score before and after 6 months of treatment to know the utility of individualized homoeopathic medicine.

时间窗: 12 weeks, 24 weeks

次要结局

  • To assess changes in the quality of life of the patient at baseline and after 6 months of treatment by comparing the changes in the Hydronephrosis Severity Score.(12 weeks, 24 weeks)

研究者

发起方
Dr Dinesh Chand
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Dinesh Chand

State National Homoeopathic Medical College and Hospital,Lucknow.

研究点 (1)

Loading locations...

相似试验